Compound 2049
Identifiers
- Canonical SMILES:
C[C@H]1CN(C(=O)c2ccccc2)c2ccccc2N1C(C)=O
- IUPAC name:
1-[(2S)-4-benzoyl-2-methyl-1,2,3,4-tetrahydroquinoxalin-1-yl]ethan-1-one
- InChi:
InChI=1S/C18H18N2O2/c1-13-12-19(18(22)15-8-4-3-5-9-15)16-10-6-7-11-17(16)20(13)14(2)21/h3-11,13H,12H2,1-2H3/t13-/m0/s1
- InChiKey:
XISWKHNXRRASFZ-ZDUSSCGKSA-N
External links
![]() 118079664 |
![]() CHEMBL4213180 |
External search
|
|
|
|
|
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|
| 0 | 0 | 0 | 0 |
Targets
| PPI family | Best activity | Diseases | MMoA |
|---|
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 294.14 g/mol | |||
| HBA | 4 | |||
| HBD | 0 | |||
| HBA + HBD | 4 | |||
| AlogP | 2.28 | |||
| TPSA | 40.62 | |||
| RB | 1 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 |
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity |
|---|
| Ta | Structure | Name | Drugbank ID |
|---|---|---|---|
| 0.6961 | Dibenzepin | DB13225 | |
| 0.6342 | Tacedinaline | DB12291 | |
| 0.6250 | Darexaban | DB12289 | |
| 0.6098 | CP1-1189 | DB12311 | |
| 0.6046 | Histapyrrodine | DB13479 | |
| 0.5926 | Procainamide | DB01035 | |
| 0.5761 | Diampromide | DB01502 | |
| 0.5632 | Bunaftine | DB13652 | |
| 0.5625 | Balicatib | DB12239 | |
| 0.5521 | Benzylfentanyl | DB09182 | |
| 0.5484 | Bentiromide | DB00522 | |
| 0.5385 | Prilocaine | DB00750 | |
| 0.5341 | 6-(N-Phenylcarbamyl)-2-Naphthalenecarboxamidine | DB01977 | |
| 0.5327 | Evocalcet | DB12388 | |
| 0.5300 | Nefiracetam | DB13082 |




